Ojemda treatment for certain patients with pediatric low-grade glioma is “well-tolerated” and may be safer than traditional ...

A novel delivery system of gemcitabine called TAR-200 led to promising responses in certain patients with non-muscle-invasive ...

As a society, we shouldn't accept the "norm" of people younger than 50 receiving diagnoses or dying from cancer.

I watched my family members go through breast and ovarian cancer diagnoses, and knew that one day, I’d have my own major medical decisions to make.

The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.

Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their ...

In addition to cigarette smoking, second-hand smoke, air pollution, exposure to radon, asbestos and other chemicals, as well ...

Patients with TP53/PPM1D mutations in their stem cell product had an increased risk of myeloid neoplasms in patients with ...

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy.

Treatment with a certain radiation therapy worsens quality of life in patients with prostate cancer. An expert explains ways ...

Good news in the cancer space is great, but we need to share more cancer stories about the good, bad and the ugly ...

Sometimes we meet strangers along the way on this cancer path, with whom we have brief, intimate connections that awaken and humble us anew again.